- Third edition of the first ever book published on pediatric psychopharmacology from renowned editors.
- Incorporates current developments with regard to SSRIs, their indications and their safety issues, including possible associated suicidal behavior.
- Addresses concerns about cardiovascular side effects of the new stimulant medications available, and compares to other FDA-approved medications for ADHD.
- Features many tables, figures and pictorials, making it highly accessible and reader friendly.